Williams, Adam D. N. http://orcid.org/0000-0002-4825-8997
Davies, Gwyneth
Farrin, Amanda J.
Mafham, Marion
Robling, Michael
Sydes, Matthew R.
Lugg-Widger, Fiona V.
Funding for this research was provided by:
MRC-NIHR Trials Methodology Research Partnership (TMRP/WG/15)
Article History
Received: 31 October 2022
Accepted: 13 March 2023
First Online: 30 March 2023
Declarations
:
: This study received ethical approval from the School of Medicine Research Ethics Committee, Cardiff University [SMREC 21/99].
: N/A.
: GD reports speaker honoraria from Vertex Pharmaceuticals and Chiesi Ltd., unrelated to the current manuscript. MM works for the Nuffield Department of Population Health which has a policy of not accepting personal payments from industry (ExternalRef removed). A list of grants to the department is available in this document. MM is a co-applicant on research grants to the University of Oxford from Novartis and Novo Nordisk. AJF is a member of the MRC Better Methods, Better Research (BMBR) panel funding methodological research, unrelated to the project funding for this manuscript. The other authors declare that they have no competing interests.